title: Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies.
abstract: The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.
authors.affiliation: Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97239-3098, USA. malempat@ohsu.edu
authors.forename: Suman
authors.initials: S
authors.lastname: Malempati
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Hawkins
mesh_terms: D000293:Adolescent; D035843:Biomedical Research / Q000458:organization & administration / Q000592:standards / Q000639:trends; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D012208:Rhabdomyosarcoma / Q000628:therapy*; D012307:Risk Factors